Global Streptokinase Market Size, Share & Trends Analysis Report, By Product (Natural and Synthetic), By Indication (Myocardial Infarction, Arterial Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis, and Others), Forecast (2022-2028)

The global streptokinase market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Streptokinase is a thrombolytic medication and enzyme that eases the blood flow in the arteries. Also available in the form of a medication, streptokinase is used to break down clots in some cases of myocardial infarction (heart attack), pulmonary embolism, and arterial thromboembolism. It is in the thrombolytic class of medications and is used in cardiovascular condition named as ST elevation myocardial infarction (STEMI). It is used by injecting it into a vein. The market growth is majorly attributable to the growing prevalence of various cardiovascular disorders such as acute ST-segment myocardial infarction, deep vein thrombosis, pulmonary embolism, arterial thrombosis or embolism, and arteriovenous cannula occlusion among the global population.

Streptokinase has been found to be useful in the management and treatment of such medical conditions. As a result, this is likely to spur the growth of the global streptokinase market. AS per the NCBI, streptokinase forms a complex with plasminogen, which then converts to the proteolytic enzyme plasmin. This process results in a cascade that ultimately leads to the lysis of fibrin clots. Streptokinase causes a systemic thrombolytic state that usually resolves within 48 hours of administration. Thus, the instant effectiveness of streptokinase is also anticipated to boost the growth of the global streptokinase market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Product
• By Indication

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape:  Dabur Pharma Ltd., Biocon Ltd., and Kee Pharma Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Streptokinase Market Report by Segment

By Product

• Natural
• Synthetic

By Indication

• Myocardial Infarction
• Arterial Thromboembolism
• Pulmonary Embolism
• Deep Vein Thrombosis
• Others

Global Streptokinase Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa